Skip to main content
Log in

Muskuläre Symptome unter Statintherapie

Muscular symptoms associated with statin therapy

  • Klinische Studien
  • Published:
Die Innere Medizin Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Cholesterol Treatment Trialists’ Collaboration (2022) Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trials. Lancet 400:832–845

    Article  Google Scholar 

  2. Moriarty PM, Thompson PD, Cannon CP, Guyton JR, Bergeron J, Zieve FJ et al (2015) Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial. J Clin Lipidol 9:758–769

    Article  PubMed  Google Scholar 

  3. Bruckert E, Hayem G, Dejager S, Yau C, Begaud B (2005) Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients—the PRIMO study. Cardiovasc Drugs Ther 19:403–414

    Article  CAS  PubMed  Google Scholar 

  4. Stroes ES, Thompson PD, Corsini A, Vladutiu GD, Raal FJ, Ray KK et al (2015) Statin-associated muscle symptoms: impact on Statin therapy – European Atherosclerosis Society Consensus panel statement on assessment, aetiology and management. Eur Heart J 36:1012–1022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ruscica M, Ferri N, Banach M, Sirtori CR, Corsini A (2022) Side effects of statins-from pathophysiology and epidemiology to diagnostic and therapeutic implications. Cardiovasc Res. https://doi.org/10.1093/cvr/cvac020

    Article  Google Scholar 

  6. Nielsen SF, Nordestgaard BG (2015) Negative statin-related news stories decrease statin persistence and increase myocardial infarction and cardiovascular mortality: a nationwide prospective cohort study. Eur Heart J. https://doi.org/10.1093/eurheartj/ehv641

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Klaus G. Parhofer.

Ethics declarations

Interessenkonflikt

K.G. Parhofer gibt folgende Interessenkonflikte an: Vortragshonorare, Honorare für Advisory Board Tätigkeit und/oder Forschungsunterstützung von folgenden Unternehmen: Akcea, Amarin, Amgen, Daiichi-Sankyo, MSD, Novartis, Regeneron, Sanofi, Silence Therapeutics und SOBI. S. Nitschmann gibt an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Redaktion

C. Bokemeyer, Hamburg

M. Hallek, Köln

C. Jacobshagen, Karlsruhe

W. Lehmacher, Köln

U. Müller-Ladner, Bad Nauheim

H. Wedemeyer, Hannover

M. Wehling, Mannheim

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parhofer, K.G., Nitschmann, S. Muskuläre Symptome unter Statintherapie. Innere Medizin 64, 295–297 (2023). https://doi.org/10.1007/s00108-022-01455-0

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-022-01455-0

Navigation